There are also technical bottlenecks which span the entire product development pipeline, and novel adjuvants are needed for vaccines for which conventional formulations have failed.
Postoje i tehnička uska grla u svim fazama razvoja proizvoda, a potrebni su i novi adjuvansi za cjepiva čije su konvencionalne formulacije neuspješne.